Abstract.-Independent 4 A electron density maps calculated for the extracellular nuclease of Staphylococcus aureus (based on data from three heavy-atom derivatives) and for a nuclease-thymidine-3',5'-diphosphate-calcium ion complex (based on a single isomorphous derivative) show about 60 per cent of the chain resolved, including 31/2 turns of helix. The pyrimidine ring of the inhibitor fits into a pocket in the enzyme and appears to be parallel to the ring of a tyrosyl residue. Conformational changes can be observed between the nuclease and the nuclease-inhibitor complex, but the two structures seem to be identical over most of the molecule.
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The extracellular nuclease of Staphylococcus aureus, a calcium ion-activated enzyme that attacks the phosphodiester bonds of both RNA and DNA, consists of a single chain of 149 amino acid residues (mol. wt. = 16,807) with no sulfhydryl or disulphide groups. C. B. Anfinsen and his associates have recently reviewed1 their extensive work on the chemistry of this nuclease, including a sequence determination and progress toward total synthesis. We previously reported the crystallization of the nuclease in several forms2; the present paper describes our further progress with an X-ray crystallographic determination of the structure.
Methods and Results.-Nuclease (Foggi strain) was purchased from Worthington Biochemical Corp. Used material was recovered and preparations that gave poor crystals were reworked, originally by recrystallization, but more recently by chromatography on phosphocellulose.3 As previously described,2 uninhibited nuclease crystals were grown in siliconed vials at 20C from a 1-2 mg/ml solution of nuclease in pH 8.15, 0.0105 M potassium phosphate buffer with 2-methyl-2,4-pentanediol4 added dropwise to a final concentration of 29-32 per cent and a final pH (at 250) of 8.6-8.7. Good crystals formed in 1-2 months; they were tetragonal, space group P41, of unit cell dimensions a = 47.75, c = 63.5 A. For nuclease-inhibitor crystals, a solution of enzyme and buffer (as above) with 22-25 per cent diol was allowed to stand at 20C for several days and then filtered through a 0.45 As pore-size i\iillipore filter in a filtering centrifuge tube. One mole per mole nuclease of thymidine-3',5'-diphosphate (pdTp), a potent inhibitor,' was added, and two moles Ca2+ in the form of 0.01 I\{ calcium chloride-0.02 1\1 potassium citrate were also added. These crystals grew more rapidly than the native nuclease crystals and were of the same space group but with unit cell dimensions of a = 48.3, c = 63.3 A. No crystals of either type that varied more than 0.1 A from the given unit cell dimensions were used. Crystal size ranged from 0.15 X 0.15 X 0.5 mm for some nuclease-pIdUp crystals to 0.4 X 0.5 X 0.7 mm for the largest uninhibited crystals. In some preparations (Fig. lb) , the polarity of the fourfold screw axis was evidenced in the external morphology: at one termination the 1,1,1 faces (diamond-shaped) were developed and at the other end the 0,1,1 faces (triangular). were soaked for about a month in a 1 X 10-4 M PAMA solution in the phosphate buffer and 40 per cent diol. Similarly, crystals were soaked in 1 X 10-4 M pchloromercuribenzene sulfonic acid (PCMBS), but the concentration was then raised in two steps at ten-day intervals to 3 X 10-4 M and maintained for one month at this molarity before crystals were removed for use. The stepwise increase in concentration reduced cracking of the extremely fragile PCMBS-soaked crystals. The heavy atom was in at least ten-fold molar excess over the nuclease in all soaks. In current practice all unsubstituted crystals and substituted crystals grown from solution are equilibrated before use in a 40 per cent diol solution of the appropriate buffer, plus 10-4 iV Ca2+ and 10-4 l\i nucleoside diphosphate for the nuclease-inhibitor crystals.
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Crystals were mounted in sealed glass capillaries, and data were collected at 2VC using a carefully aligned,9 Datex-controlled, General Electric XRD-6 diffractometer with an Electronics and Alloys full-circle goniometer. We have modified this instrument to allow a range of -45 to + 1000 in 2 0, provided for interchangeable nosepieces on the incident-beam collimator, and added a diffracted-VOL. 64, 1969 421.
beam aperture of variable position and size.'0 Intensities were measured by the stationary-crystal, stationary-counter method at a takeoff angle of 60, using copper radiation and a pair of balanced filters. An additional background correction was applied as a function of 20. Absorption correction curves were measured by taking scans of the 0,0,1 reflections at x = 900. For our case of crystals with approximately square cross section, the absorption correction was almost entirely due to the capillary and was the same at + 20 and -20. Ten reflections were measured at +20, followed by the Friedel pairs at -2 0, with standard test reflections inserted every 100. A crystal was discarded when the average intensity dropped more than 5 per cent or the unit cell size changed. All independent reflections within the 4 A sphere were collected (2800, including Friedel pairs). Each reflection of each crystal type was measured at least twice, because we found that anomalous-dispersion differences front a single set of data were not statistically accurate enough to give clean crossFourier maps.
After the raw data had been corrected and measurements from separate crystals of the same type had been averaged, data for substituted crystals were shell-scaled to match their intensity falloff with 2 0 to that of the natural crystal data. Using anomalous-dispersion measurements, FH was calculated by Mathews' formula.t An overall scale factor between the natural and the sub- The X and Y coordinates of the heavy atoms were estimated from threedimensional Patterson maps (Fig. 2a) . Three-dimensional cross-Fourier"3 maps were used to check the X and Y positions and to determine relative Z coordinates ( Figs. 2b and 3a) . At this step, the anomalous difference was used only to choose between the two possible solutions of the phase triangle for FH. The first such cross-Fourier was used to choose between space groups P41 and P43. Phases for Fp were calculated from the PtCl42-substitution and applied to the PATMA data (Figs. 3a and 3b) ; when P41 was assumed the cross-Fourier showed the two close PAMA sites, but when P43 was assumed, the map showed only random, lowlevel noise.
Heavy-atom coordinates, relative occupancies, and temperature parameters were refined by standard least-square techniques, using the M.I.T. time-sharing system. Allowance was made during later cycles for centric reflection "crossovers" through zero'4 and also for the analogous noncentric case of an obtuse angle between Fp and FPH; the "crossover" value is chosen in refinement for (see footnotet) about 1 per cent of the reflections. Refinement results are summarized in Table 1 . Native-crystal phases were calculated from the centroid of the combined probability distribution as described by Blow and Crick'6 and by Dickerson, Kendrew, and Strandberg.'6 Isomorphous and anomalous distributions were calculated separately as suggested by North'7 to allow for the difference in their root mean square errors. "Best" Fourier maps", 16 of the nuclease and of the nuclease-inhibitor complex were generated from these phases. The phases for the nuclease-inhibitor map were based on the single, highly isomorphous substitution of an iodine for the methyl group on the thymidine-3',5'-diphosphate. Since no information from the uninhibited nuclease data was used in processing the nuclease-inhibitor data except for the choice of a relative Z coordinate for the iodine, the great similarity of the two maps provides strong evidence that both are essentially correct.
An anomalous-difference Fourier map"8 calculated from the unsubstituted nuclease-inhibitor-Ca2+ complex data shows a single sharp peak 2-3 times above (Fig. 4) . We assigned this to a Ca2 , since the bound Ca2+ was the strongest anomalous scatterer in these crystals and this was the same position where a single barium atom had been located in another set of substitution trials. Working at higher pH than that used in growing the crystals, Cuatrecasas et al.I 9 have shown that a second calcium ion is also involved in pdTp binding, but we have found no indication of it.
Discussion.-From a 6 A electron density map of the native nuclease, the boundaries of a molecule could be determined (as in the styrofoam model, Fig. 5 ) and there were indications of where helical sections of chain and the binding site might be located.
By comparing the 4 A maps of the native and the inhibited nuclease, the binding site of the pdTp could be located quite unambiguously in the area to the top left front in Figure 5 . The added electron density can be fitted in considerable detail: the pyrimidine ring of the pdTp fits into the well-defined "pocket," with the 3'-phosphate toward the top of the molecule and the 5'-phosphate down close to the Ca2+ position (see Fig. 6 ). The pyrimidine ring is parallel to and about 3.5 A from what we tentatively identify as the ring of a tyrosine residue, both from its shape and because Cuatracasas et al. 20 have shown that binding of thymidine-3',5'-diphosphate dramatically affects the reactivity of two of the tyrosine residues. Upon inhibitor binding, the side chains of this residue and an adjacent one appear to rotate about 900, aligning the tryosine ring parallel to the pyrimidine ring of the thymidine-3',5'-diphosphate. On the right-hand side of the molecule, as seen in Figure 5 , the chain can be traced back and forth in three antiparallel sections which form an almost vertical sheet above the helix. The path of the backbone chain can be readily followed for about two-thirds of its length, but in several places the connectivity is unclear.
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